{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:07:04Z","timestamp":1794326824318,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007380","name":"Fondation de l'Avenir pour la Recherche M\u00e9dicale Appliqu\u00e9e","doi-asserted-by":"publisher","award":["AP-RM-22-006"],"award-info":[{"award-number":["AP-RM-22-006"]}],"id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["MetaboHUB-ANR-11-INBS-0010"],"award-info":[{"award-number":["MetaboHUB-ANR-11-INBS-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Asfalia biologics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Despite significant advancements, the effectiveness of chimeric antigen receptor (CAR)-T-cell-based therapies in solid tumors remains limited. Key challenges include on-target effects, off-tumor toxicity and reduced CAR-T-cell function within the tumor microenvironment, which is often characterized by metabolic stress triggered by factors such as amino acid scarcity. Activating transcription factor-4 (ATF4) and its upstream regulator GCN2 play crucial roles in the metabolic reprogramming and functionality of CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells. ATF4 can be activated by various cellular stress signals, including amino acid deprivation. While ATF4 activation may be associated with T-cell dysfunction, its role in stress adaptation presents an opportunity for therapeutic intervention\u2014particularly in the tumor microenvironment, where T-cell exhaustion is a major challenge. In this study, we developed a strategy to harness the GCN2\u2012ATF4 axis in CAR-T cells. We employed an amino acid-dependent inducible promoter, which triggers ATF4-dependent gene expression to regulate CAR expression in T cells under conditions of amino acid scarcity within the tumor microenvironment. In vitro and murine xenograft models demonstrate the potential of this system to effectively restrict CAR expression to the tumor site. This targeted strategy not only enhances safety by minimizing off-tumor activity but also CAR-T-cell fitness by reducing exhaustion. By validating this pathophysiologically regulatable CAR expression system for solid tumors, our findings address key limitations of current CAR-T-cell therapies and pave the way for innovative strategies targeting solid malignancies.<\/jats:p>","DOI":"10.1038\/s41423-025-01290-x","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T02:03:25Z","timestamp":1746669805000},"page":"645-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors"],"prefix":"10.1038","volume":"22","author":[{"given":"Enzo","family":"Manchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nell","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Versier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravindhan","family":"Soundiramourty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Juricek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-7836","authenticated-orcid":false,"given":"Nabila","family":"Jabrane-Ferrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che","family":"Serguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Al-Daccak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"1290_CR1","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507\u201317.","journal-title":"N Engl J Med"},{"key":"1290_CR2","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.20.01467","volume":"38","author":"KM Cappell","year":"2020","unstructured":"Cappell KM, Sherry RM, Yang JC, Goff SL, Vanasse DA, McIntyre L, et al. Long-term follow-up of anti-CD19 chimeric antigen receptor T-cell therapy. J Clin Oncol. 2020;38:3805\u201315.","journal-title":"J Clin Oncol"},{"key":"1290_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt.1674","volume":"107","author":"SA Holstein","year":"2020","unstructured":"Holstein SA, Lunning MA. CAR T-Cell Therapy in hematologic malignancies: a voyage in progress. Clin Pharmacol Ther. 2020;107:112\u201322.","journal-title":"Clin Pharmacol Ther"},{"key":"1290_CR4","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.3390\/jcm12196124","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Qin D, Shou AC, Liu Y, Wang Y, Zhou L. Exploring CAR-T-Cell therapy side effects: mechanisms and management strategies. J Clin Med. 2023;12:6124.","journal-title":"J Clin Med"},{"key":"1290_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1080\/1744666X.2023.2248390","volume":"19","author":"K Saleki","year":"2023","unstructured":"Saleki K, Mohamadi MH, Alijanizadeh P, Rezaei N. Neurological adverse effects of chimeric antigen receptor T-cell therapy. Expert Rev Clin Immunol. 2023;19:1361\u201383.","journal-title":"Expert Rev Clin Immunol"},{"key":"1290_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","volume":"25","author":"LA Kankeu Fonkoua","year":"2022","unstructured":"Kankeu Fonkoua LA, Sirpilla O, Sakemura R, Siegler EL, Kenderian SS. CAR T-cell therapy and the tumor microenvironment: Current challenges and opportunities. Mol Ther Oncol. 2022;25:69\u201377.","journal-title":"Mol Ther Oncol"},{"key":"1290_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","volume":"20","author":"CL Flugel","year":"2023","unstructured":"Flugel CL, Majzner RG, Krenciute G, Dotti G, Riddell SR, Wagner DL, et al. Overcoming on-target, off-tumor toxicity of CAR T-cell therapy for solid tumors. Nature Rev Clin Oncol. 2023;20:49\u201362.","journal-title":"Nature Rev Clin Oncol"},{"key":"1290_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM. CAR-T-cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11:69.","journal-title":"Blood Cancer J"},{"key":"1290_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2021.06.012","volume":"39","author":"GM Delgoffe","year":"2021","unstructured":"Delgoffe GM, Xu C, Mackall CL, Green MR, Gottschalk S, Speiser DE, et al. The role of exhaustion in CAR T-cell therapy. Cancer Cell. 2021;39:885\u20138.","journal-title":"Cancer Cell"},{"key":"1290_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, Ming Y, Wu J, Cui G. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cellular Mol Immunol. 2024;21:419\u201335.","journal-title":"Cellular Mol Immunol"},{"key":"1290_CR11","doi-asserted-by":"publisher","first-page":"17422","DOI":"10.3390\/ijms242417422","volume":"24","author":"X Zhang","year":"2023","unstructured":"Zhang X, Song W, Gao Y, Zhang Y, Zhao Y, Hao S, et al. The role of tumor metabolic reprogramming in tumor immunity. Int J Mol Sci. 2023;24:17422.","journal-title":"Int J Mol Sci"},{"key":"1290_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.50","volume":"5","author":"KL Eales","year":"2016","unstructured":"Eales KL, Hollinshead KER, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016;5:e190.","journal-title":"Oncogenesis"},{"key":"1290_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123192","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wu X, Chen H-N, Wang K. Amino acid metabolic reprogramming in tumor metastatic colonization. Frontiers Oncol. 2023;13:1123192.","journal-title":"Frontiers Oncol"},{"key":"1290_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/156652409788167096","volume":"9","author":"J Ye","year":"2009","unstructured":"Ye J, Koumenis C. ATF4, an ER Stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Current Mol Med. 2009;9:411\u20136.","journal-title":"Current Mol Med"},{"key":"1290_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1566524016666160523143937","volume":"16","author":"W Rozpedek","year":"2016","unstructured":"Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The Role of the PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Current Mol Med. 2016;16:533\u201344.","journal-title":"Current Mol Med"},{"key":"1290_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tem.2009.05.008","volume":"20","author":"MS Kilberg","year":"2009","unstructured":"Kilberg MS, Shan J, Su N. ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol Metab TEM. 2009;20:436\u201343.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"1290_CR17","doi-asserted-by":"publisher","first-page":"24120","DOI":"10.1074\/jbc.M201959200","volume":"277","author":"F Siu","year":"2002","unstructured":"Siu F, Bain PJ, LeBlanc-Chaffin R, Chen H, Kilberg MS. ATF4 Is a Mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J Biol Chem. 2002;277:24120\u20137.","journal-title":"J Biol Chem"},{"key":"1290_CR18","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1093\/nar\/gkt563","volume":"41","author":"W B\u2019chir","year":"2013","unstructured":"B\u2019chir W, Maurin A-C, Carraro V, Averous J, Jousse C, Muranishi Y, et al. The eIF2\u03b1\/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013;41:7683\u201399.","journal-title":"Nucleic Acids Res"},{"key":"1290_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/bj3390135","volume":"339","author":"TW Fawcett","year":"1999","unstructured":"Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ. Complexes containing activating transcription factor (ATF)\/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT\/enhancer-binding protein (C\/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J. 1999;339:135\u201341.","journal-title":"Biochem J"},{"key":"1290_CR20","doi-asserted-by":"publisher","first-page":"e15716","DOI":"10.1371\/journal.pone.0015716","volume":"5","author":"V Carraro","year":"2010","unstructured":"Carraro V, Maurin AC, Lambert-Langlais S, Averous J, Chaveroux C, Parry L, et al. Amino acid availability controls TRB3 transcription in liver through the GCN2\/eIF2alpha\/ATF4 pathway. PLoS ONE. 2010;5:e15716.","journal-title":"PLoS ONE"},{"key":"1290_CR21","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.celrep.2018.04.032","volume":"23","author":"X Yang","year":"2018","unstructured":"Yang X, Xia R, Yue C, Zhai W, Du W, Yang Q, et al. ATF4 Regulates CD4+ T-Cell Immune Responses through Metabolic Reprogramming. Cell Rep. 2018;23:1754\u201366.","journal-title":"Cell Rep"},{"key":"1290_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113995","volume":"43","author":"Z Zou","year":"2024","unstructured":"Zou Z, Cheng Q, Zhou J, Guo C, Hadjinicolaou AV, Salio M, et al. ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition. Cell Rep. 2024;43:113995.","journal-title":"Cell Rep"},{"key":"1290_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","volume":"5","author":"JNR Gnanaprakasam","year":"2023","unstructured":"Gnanaprakasam JNR, Kushwaha B, Liu L, Chen X, Kang S, Wang T, et al. Asparagine restriction enhances CD8+ T-cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response. Nature Metab. 2023;5:1423\u201339.","journal-title":"Nature Metab"},{"key":"1290_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09263-1","volume":"10","author":"Y Cao","year":"2019","unstructured":"Cao Y, Trillo-Tinoco J, Sierra RA, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C\/EBP homologous protein thwarts effector T-cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280.","journal-title":"Nat Commun"},{"key":"1290_CR25","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) T cells. Cell. 2024;187:2288\u2013304.e27.","journal-title":"Cell"},{"key":"1290_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00262-022-03286-2","volume":"72","author":"Z Lu","year":"2023","unstructured":"Lu Z, Bae E-A, Verginadis II, Zhang H, Cho C, McBrearty N, et al. Induction of the activating transcription factor-4 in the intratumoral CD8+\u2009T cells sustains their viability and anti-tumor activities. Cancer Immunol Immunother CII. 2023;72:815\u201326.","journal-title":"Cancer Immunol Immunother CII"},{"key":"1290_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00262-019-02441-6","volume":"69","author":"A Rashidi","year":"2020","unstructured":"Rashidi A, Miska J, Lee-Chang C, Kanojia D, Panek WK, Lopez-Rosas A, et al. GCN2 is essential for CD8(+) T-cell survival and function in murine models of malignant glioma. Cancer Immunol Immunother. 2020;69:81\u201394.","journal-title":"Cancer Immunol Immunother"},{"key":"1290_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/nbt.3582","volume":"34","author":"C Chaveroux","year":"2016","unstructured":"Chaveroux C, Bruhat A, Carraro V, Jousse C, Averous J, Maurin A-C, et al. Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids. Nature Biotechnol. 2016;34:746\u201351.","journal-title":"Nature Biotechnol"},{"key":"1290_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn RC, Weber EW, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293\u2013300.","journal-title":"Nature"},{"key":"1290_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","volume":"629","author":"AE Doan","year":"2024","unstructured":"Doan AE, Mueller KP, Chen AY, Rouin GT, Chen Y, Daniel B, et al. FOXO1 is a master regulator of memory programming in CAR T cells. Nature. 2024;629:211\u20138.","journal-title":"Nature"},{"key":"1290_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118448","volume":"14","author":"M Yu","year":"2023","unstructured":"Yu M, Zhang S. Influenced tumor microenvironment and tumor immunity by amino acids. Front Immunol. 2023;14:1118448.","journal-title":"Front Immunol"},{"key":"1290_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife. 2019;8:e44235.","journal-title":"eLife"},{"key":"1290_CR33","doi-asserted-by":"publisher","first-page":"e22560","DOI":"10.1371\/journal.pone.0022560","volume":"6","author":"S Yang","year":"2011","unstructured":"Yang S, Liu F, Wang QJ, Rosenberg SA, Morgan RA. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS ONE. 2011;6:e22560.","journal-title":"PLoS ONE"},{"key":"1290_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/intimm\/dxac024","volume":"34","author":"R Koyama-Nasu","year":"2022","unstructured":"Koyama-Nasu R, Wang Y, Hasegawa I, Endo Y, Nakayama T, Kimura MY. The cellular and molecular basis of CD69 function in anti-tumor immunity. Int Immunol. 2022;34:555\u201361.","journal-title":"Int Immunol"},{"key":"1290_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"J-C Beltra","year":"2020","unstructured":"Beltra J-C, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, et al. Developmental Relationships of Four Exhausted CD8+ T-Cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity. 2020;52:825\u201341.e8.","journal-title":"Immunity"},{"key":"1290_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","volume":"17","author":"NR Maimela","year":"2019","unstructured":"Maimela NR, Liu S, Zhang Y. Fates of CD8+ T cells in Tumor Microenvironment. Comput Struct Biotechnol J. 2019;17:1\u201313.","journal-title":"Comput Struct Biotechnol J"},{"key":"1290_CR37","doi-asserted-by":"crossref","unstructured":"Kirsh SM, Pascetta SA, Uniacke J. Spheroids as a 3D Model of the Hypoxic Tumor Microenvironment. In: Ursini-Siegel J, editor. The Tumor Microenvironment. 2614. New York, NY: Springer US; 2023. p. 273\u201385.","DOI":"10.1007\/978-1-0716-2914-7_17"},{"key":"1290_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s42003-020-0973-6","volume":"3","author":"S Lagies","year":"2020","unstructured":"Lagies S, Schlimpert M, Neumann S, W\u00e4ldin A, Kammerer B, Borner C, et al. Cells grown in three-dimensional spheroids mirror in vivo metabolic response of epithelial cells. Commun Biol. 2020;3:246.","journal-title":"Commun Biol"},{"key":"1290_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1809","volume":"6","author":"Z Ghanbari Movahed","year":"2023","unstructured":"Ghanbari Movahed Z, Matin MM, Mansouri K, Sisakhtnezhad S. Amino acid profile changes during enrichment of spheroid cells with cancer stem cell properties in MCF -7 and MDA-MB -231 cell lines. Cancer Rep. 2023;6:e1809.","journal-title":"Cancer Rep"},{"key":"1290_CR40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2019.09.023","volume":"519","author":"N Wang","year":"2019","unstructured":"Wang N, Zeng G-Z, Yin J-L, Bian Z-X. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt\u2019s Lymphoma. Biochem Biophys Res Commun. 2019;519:533\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1290_CR41","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/cancers14040902","volume":"14","author":"M Van Trimpont","year":"2022","unstructured":"Van Trimpont M, Peeters E, De Visser Y, Schalk AM, Mondelaers V, De Moerloose B, et al. Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers. 2022;14:902.","journal-title":"Cancers"},{"key":"1290_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113568","volume":"426","author":"J Blachier","year":"2023","unstructured":"Blachier J, Cleret A, Guerin N, Gil C, Fanjat J-M, Tavernier F, et al. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase. Exp Cell Res. 2023;426:113568.","journal-title":"Exp Cell Res"},{"key":"1290_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1786","volume":"372","author":"EW Weber","year":"2021","unstructured":"Weber EW, Parker KR, Sotillo E, Lynn RC, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372:eaba1786.","journal-title":"Science"},{"key":"1290_CR44","doi-asserted-by":"publisher","first-page":"e150807","DOI":"10.1172\/JCI150807","volume":"132","author":"S Arcangeli","year":"2022","unstructured":"Arcangeli S, Bove C, Mezzanotte C, Camisa B, Falcone L, Manfredi F, et al. CAR T-cell manufacturing from naive\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome. J Clin Investig. 2022;132:e150807.","journal-title":"J Clin Investig"},{"key":"1290_CR45","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.annonc.2021.07.018","volume":"32","author":"D Meyran","year":"2021","unstructured":"Meyran D, Terry RL, Zhu JJ, Haber M, Ziegler DS, Ekert PG, et al. Early-phenotype CAR-T cells for the treatment of pediatric cancers. Annals Oncol. 2021;32:1366\u201380.","journal-title":"Annals Oncol"},{"key":"1290_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03315-3","volume":"24","author":"T Chen","year":"2024","unstructured":"Chen T, Wang M, Chen Y, Liu Y. Current challenges and therapeutic advances of CAR-T-cell therapy for solid tumors. Cancer Cell Int. 2024;24:133.","journal-title":"Cancer Cell Int"},{"key":"1290_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1546172","volume":"16","author":"S Gomez-Melero","year":"2025","unstructured":"Gomez-Melero S, Hassouneh F, Vallejo-Bermudez IM, Aguera-Morales E, Solana R, Caballero-Villarraso J. Tandem CAR-T-cell therapy: recent advances and current challenges. Front Immunol. 2025;16:1546172.","journal-title":"Front Immunol"},{"key":"1290_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13046-023-02845-4","volume":"42","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Yao Y, Ge T, Ge S, Jia R, Song X, et al. Amino acid metabolism reprogramming: shedding new light on T-cell anti-tumor immunity. J Exp Clin Cancer Res. 2023;42:291.","journal-title":"J Exp Clin Cancer Res"},{"key":"1290_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian Y, Li W, Kremer DM, Sajjakulnukit P, Li S, Crespo J, et al. Cancer SLC43A2 alters T-cell methionine metabolism and histone methylation. Nature. 2020;585:277\u201382.","journal-title":"Nature"},{"key":"1290_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","volume":"80","author":"W Wang","year":"2020","unstructured":"Wang W, Zou W. Amino acids and their transporters in T-cell immunity and cancer therapy. Mol Cell. 2020;80:384\u201395.","journal-title":"Mol Cell"},{"key":"1290_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","volume":"16","author":"L Yang","year":"2023","unstructured":"Yang L, Chu Z, Liu M, Zou Q, Li J, Liu Q, et al. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J Hematol Oncol. 2023;16:59.","journal-title":"J Hematol Oncol"},{"key":"1290_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/10409238.2019.1611733","volume":"54","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Vander Heiden MG. Determinants of nutrient limitation in cancer. Crit Rev Biochem Mol Biol. 2019;54:193\u2013207.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1290_CR53","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1126\/science.aar5986","volume":"360","author":"A Muir","year":"2018","unstructured":"Muir A, Vander Heiden MG. The nutrient environment affects therapy. Science. 2018;360:962\u20133.","journal-title":"Science"},{"key":"1290_CR54","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","volume":"80","author":"JK Byun","year":"2020","unstructured":"Byun JK, Park M, Lee S, Yun JW, Lee J, Kim JS, et al. Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Mol Cell. 2020;80:592\u2013606.e8.","journal-title":"Mol Cell"},{"key":"1290_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38316-9","volume":"14","author":"M Pandit","year":"2023","unstructured":"Pandit M, Kil YS, Ahn JH, Pokhrel RH, Gu Y, Mishra S, et al. Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells. Nat Commun. 2023;14:2593.","journal-title":"Nat Commun"},{"key":"1290_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100227","volume":"2","author":"P Kosti","year":"2021","unstructured":"Kosti P, Opzoomer JW, Larios-Martinez KI, Henley-Smith R, Scudamore CL, Okesola M, et al. Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors. Cell Rep Med. 2021;2:100227.","journal-title":"Cell Rep Med"},{"key":"1290_CR57","doi-asserted-by":"publisher","first-page":"rs5","DOI":"10.1126\/scisignal.aaa0549","volume":"8","author":"C Chaveroux","year":"2015","unstructured":"Chaveroux C, Carraro V, Canaple L, Averous J, Maurin A-C, Jousse C, et al. In vivo imaging of the spatiotemporal activity of the eIF2\u03b1-ATF4 signaling pathway: Insights into stress and related disorders. Sci Signal. 2015;8:rs5.","journal-title":"Sci Signal"},{"key":"1290_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20061890","volume":"204","author":"A Boissonnas","year":"2007","unstructured":"Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S. In vivo imaging of cytotoxic T-cell infiltration and elimination of a solid tumor. J Exp Med. 2007;204:345\u201356.","journal-title":"J Exp Med"},{"key":"1290_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","volume":"33","author":"J Chen","year":"2023","unstructured":"Chen J, Qiu S, Li W, Wang K, Zhang Y, Yang H, et al. Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T-cell fitness. Cell Res. 2023;33:341\u201354.","journal-title":"Cell Res"},{"key":"1290_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11321","volume":"7","author":"MJ Lukey","year":"2016","unstructured":"Lukey MJ, Greene KS, Erickson JW, Wilson KF, Cerione RA. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy. Nat Commun. 2016;7:11321.","journal-title":"Nat Commun"},{"key":"1290_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104325","volume":"25","author":"R Serna","year":"2022","unstructured":"Serna R, Ramrakhiani A, Hernandez JC, Chen CL, Nakagawa C, Machida T, et al. c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity. iScience. 2022;25:104325.","journal-title":"iScience"},{"key":"1290_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10393-x","volume":"22","author":"P Zhu","year":"2022","unstructured":"Zhu P, Liu G, Wang X, Lu J, Zhou Y, Chen S, et al. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis. BMC Cancer. 2022;22:1283.","journal-title":"BMC Cancer"},{"key":"1290_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Knopper K, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1alpha-mediated glycolytic reprogramming. Nat Commun. 2023;14:6858.","journal-title":"Nat Commun"},{"key":"1290_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1158\/0008-5472.CAN-23-1038","volume":"84","author":"X Zhu","year":"2024","unstructured":"Zhu X, Chen J, Li W, Xu Y, Shan J, Hong J, et al. Hypoxia-Responsive CAR-T cells exhibit reduced exhaustion and enhanced efficacy in solid tumors. Cancer Res. 2024;84:84\u2013100.","journal-title":"Cancer Res"},{"key":"1290_CR65","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s42003-021-01664-7","volume":"4","author":"Y Greenshpan","year":"2021","unstructured":"Greenshpan Y, Sharabi O, Ottolenghi A, Cahana A, Kundu K, Kundu K, et al. Synthetic promoters to induce immune-effectors into the tumor microenvironment. Commun Biol. 2021;4:143.","journal-title":"Commun Biol"},{"key":"1290_CR66","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/88115","volume":"19","author":"V Zennou","year":"2001","unstructured":"Zennou V, Serguera C, Sarkis C, Colin P, Perret E, Mallet J, et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nature Biotechnol. 2001;19:446\u201350.","journal-title":"Nature Biotechnol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01290-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:02:15Z","timestamp":1748642535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01290-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01290-x","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Benjamin Versier, Aravindhan Soundiramourty, Yves Christen, Dominique Charron, Jacques Mallet, and Che Serguera serve Asfalia Biologics. Ludmila Juricek previously served at Asfalia Biologics and currently serves for Coave Therapeutics. The authors declare that a patent application related to this work has been filed. The other authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}